Diligence memo · auto-generated · as of July 2, 2026
Radiorx, Inc.
Radiorx, Inc. looks fair against its niche peers and is dormant on financing cadence.
Businessfiled
Radiorx, Inc. operates in Biotechnology, based in MOUNTAIN VIEW.
No verified homepage on file yet — operating evidence is limited to the public record.
Capital & rounds (filed)filed
Radiorx, Inc. has raised $48M in disclosed capital across 3 recorded rounds, aggregated from public filings. Its latest round is modeled as Series B (a $15M–$40M round).
Largest single filing: $20M on 2008-05-14.
Most recent recorded round closed around 2008-05-14.
Valuation (modeled)modeled
Provath models Radiorx, Inc. at approximately $812M (range $41M–$3.1B). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Read: Fair. Modeled value is 0.91× the median modeled value of Series B Biotechnology companies in 2007–2009 (21 peers) — value vs value, same stage and era. Within the normal band (91% of peer median) for its niche.
Financing rhythm & timingmixed
Last raise 18.1 yr ago; this sector typically re-raises about every 14 months.
Silent for over 3× the sector's normal cadence.
The last round was 1.5× smaller than the prior — a bridge or down round.
Comparablesmixed
Capital scale ranks ahead of 81% of Biotechnology peers (4293 compared).
Modeled value ranks above 87% of those peers.
Closest niche peers: Ion Torrent Systems Inc, PhotoThera Inc, Taligen Therapeutics Inc, Atritech Inc, Barosense Inc.
Peoplefiled
4 named people on file across officers, directors and signatories.
Risks & flagsmixed
Financing has been silent well beyond sector cadence — possibly defunct, acquired, or paused.
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.